Expression of the c-Fos gene in hypothalamic cells and Cytotoxic activity of natural killer cells in the spleen of rats after treatment with Cytoxan

Bulletin of Experimental Biology and Medicine

Volumn 141, Issue 4, 2006, Pages 394-396

  Rybakina, E G ^a   Novikova, N S ^a   Abramova, T V ^a   Shanin, S N ^a   Kozinets, I A ^a   Rogers, V ^b   Korneva, E A ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b Institute for Biological Information Processing   (United States)

Author keywords

C Fosprotein; Cytoxan; Natural killer cells

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL COUNT; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; GENE EXPRESSION; HYPOTHALAMUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; LATERAL HYPOTHALAMUS; MALE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEUROTOXICITY; NONHUMAN; RAT; SPLEEN; SPLEEN CELL;

ANIMALS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HYPOTHALAMUS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; KILLER CELLS, NATURAL; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; SPLEEN;

EID: 33746472431     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-006-0180-6     Document Type: Article

References (11)

1. F. I. Ershov, Interferon System under Normal and Pathological Conditions [in Russian], Moscow (1996).
2. H. Ben-Hur, G. Kossoy, Y. Tendler, et al., In Vivo, 16, No. 5, 287-292 (2002).
3. Brain Maps: Computer Graphic Files, Ed. L. W. Swanson, Amsterdam (1992).
4. Handbook of Immunoperoxidase Staining Methods, Ed. J. A. Bourue, Santa Barbara (1983).
5. V. R. Makar, M. K. Logani, A. Bhanushall, et al., Bioelectromagnetics, 26, 10-19 (2005).
6. R. Martinelli, L. S. Pereira, E. S. Santos, and H. Rocha, Nefron, 74, No. 2, 313-317 (1996).
7. N. S. Novikova, T. V. Kazakova, V. J. Rogers, and E. A. Korneva, Neuroendocronol. Lett., 23, No. 4, 315-320 (2002).
8. C. A. O'Reilly and J. H. Exon, Physiol. Behav., 37, 759-764 (1986).
9. H. W. Smith, C. J. Winstead, K. K. Stank, et al., Toxicology, 194, Nos. 1-2, 129-145 (2003).
10. L. S. Stewart, L. S. Sewell, and A. W. Thompson, Clin. Exp. Immunol., 79, No. 3, 416-423 (1990).
11. M. Wenner, N. Kawamura, and T. Ishikawa, Neuroimmunomodulation, 7, No. 1, 1-5 (2000).